STAT4 and systemic sclerosis: IL-35 is known to signal via STAT1 and STAT4, consequently, the molecular mechanisms of IL-35 in systemic sclerosis were adduced to IL-35 mediated influence of pro-fibrotic STAT4 clones on T cell activation, expansion as well as patterns of cytokine release [59].